Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The aim of this study is to assess the Fecal Microbiota Transplantation (FMT) efficacy in the prevention of allogeneic hematopoietic stem cell transplantation (allo-HSCT) complications and particularly Graft versus Host Disease (GvHD). The hypothesis of this study is that allogeneic FMT may improve outcomes of these patients.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek 18 lat lub więcej
- •Mężczyźni i kobiety
- •Pacjenci ubezpieczeni w systemie ubezpieczenia społecznego
- •Pacjenci przygotowywani do przeszczepiania komórek macierzystych od niespokrewnionego dawcy
- •Podpisana świadoma zgoda na udział w badaniu
✗ Disqualifies
- •Progresja choroby nowotworowej w momencie przeszczepiania
- •Niezdolność do zrozumienia protokołu badania
- •Inny nowotwór w ciągu ostatnich 3 lat
- •Poważne choroby serca, nerek, wątroby lub płuc
- •Niezwolnienie stolca
- •Udział w innym badaniu nad przeszczepem
- •Ciąża
- •Pacjent pod opieką sądową lub nadzorem prokuratora
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- September 21, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (20)
Service d'Hématologie Clinique et Thérapie Cellulaire CHU Amiens Picardie - Site Sud
Amiens, France
Service Maladies du sang CHU Angers
Angers, France
Hématologie clinique CHU Besançon
Besançon, France
Plateforme d'Investigation Clinique / Centre d'Investigation Clinique - Inserm 1405, CHU Gabriel Montpied Clermont-Ferrand
Clermont-Ferrand, France
Service de thérapie Cellulaire et d'Hématologie Clinique Adulte CHU Estaing - Clermont-Ferrand
Clermont-Ferrand, France
Service hématologie CHU Grenoble
Grenoble, France
Service des Maladies du sang Hôpital HURIEZ, CHRU de Lille
Lille, France
Service de thérapie cellulaire et l'hématologie clinique adulte CHU Limoges
Limoges, France
Service d'Hématologie Centre Hospitalier Lyon Sud
Lyon, France
Service d'Hématologie et de Médecine interne Hôpital Brabois CHRU Nancy
Nancy, France
Service d'Hématologie Clinique CHU Nantes
Nantes, France
Service d'hématologie clinique, département de greffe de moelle CHU Nice
Nice, France
Service d'Hématologie Adultes Hôpital Necker
Paris, France
Service d'Hématologie clinique Hôpital Pitié-Salpêtrière
Paris, France
Service d'hématologie greffe Hôpital St Louis
Paris, France
Hématologie clinique et thérapie cellulaire Hôpital Haut-Lévèque
Pessac, France
Service d'hématologie greffe Hôpital St Louis
Poitiers, France
Département d'hématologie CAC Rouen
Rouen, France
Hématologie clinique Institut de Cancérologie de la Loire
Saint-Etienne, France
IUC T - Oncopôle
Toulouse, France
Trial contact
Lise LACLAUTRE
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/22/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.